Home  »  Companies   »  ImmunoGen Inc. (IMGN) Shares Decline Despite Marke...

ImmunoGen Inc. (IMGN) Shares Decline Despite Market Challenges

ImmunoGen Inc. (NASDAQ: IMGN) has experienced a decline in its stock price by -3.79 compared to its previous closing price of 14.53. However, the company has seen a gain of 2.12% in its stock price over the last five trading days. The Wall Street Journal reported on 02/15/22 that Virgin Galactic, Tower Semiconductor, CrowdStrike, Bitcoin: What to Watch in the Stock Market Today

Is It Worth Investing in ImmunoGen Inc. (NASDAQ: IMGN) Right Now?

Moreover, the 36-month beta value for IMGN is 0.74. Analysts have varying opinions on the stock, with 9 analysts rating it as a “buy,” 1 as “overweight,” 2 as “hold,” and 0 as “sell.”

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


The average price recommended by analysts for ImmunoGen Inc. (IMGN) is $14.40, which is $0.98 above the current market price. The public float for IMGN is 219.84M and currently, short sellers hold a 10.51% of that float. On May 24, 2023, IMGN’s average trading volume was 6.63M shares.

IMGN’s Market Performance

IMGN’s stock has seen a 2.12% increase for the week, with a 246.04% rise in the past month and a 253.92% gain in the past quarter. The volatility ratio for the week is 5.65%, and the volatility levels for the past 30 days are at 8.27% for ImmunoGen Inc. The simple moving average for the last 20 days is 27.70% for IMGN’s stock, with a simple moving average of 154.04% for the last 200 days.

IMGN Trading at 106.90% from the 50-Day Moving Average

After a stumble in the market that brought IMGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.21% of loss for the given period.

Volatility was left at 8.27%, however, over the last 30 days, the volatility rate increased by 5.65%, as shares surge +239.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +246.04% upper at present.

During the last 5 trading sessions, IMGN rose by +2.12%, which changed the moving average for the period of 200-days by +156.51% in comparison to the 20-day moving average, which settled at $11.44. In addition, ImmunoGen Inc. saw 181.85% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for IMGN

Current profitability levels for the company are sitting at:

  • -203.06 for the present operating margin
  • +98.20 for the gross margin

The net margin for ImmunoGen Inc. stands at -204.93. The total capital return value is set at -75.06, while invested capital returns managed to touch -78.74. Equity return is now at value -135.90, with -67.60 for asset returns.

Based on ImmunoGen Inc. (IMGN), the company’s capital structure generated 30.39 points at debt to equity in total, while total debt to capital is 23.31. Total debt to assets is 13.57, with long-term debt to equity ratio resting at 22.20. Finally, the long-term debt to capital ratio is 17.03.

When we switch over and look at the enterprise to sales, we see a ratio of 28.96, with the company’s debt to enterprise value settled at 0.05. The receivables turnover for the company is 6.82 and the total asset turnover is 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.50.


To wrap up, the performance of ImmunoGen Inc. (IMGN) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.